NCT06382467View on ClinicalTrials.gov

Comparison of Remimazolam and Propofol Combination vs. Propofol in IOM

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
Neurologic Disorder
Interventions
DRUG

Remimazolam besylate + propofol MCT

remimazolam besylate 3mg/kg/hr for induction, and 0.5 mg/kg/hr for maintenance + propofol MCT 1-4 mcg/ml using target-controlled infusion

DRUG

Propofol MCT

Propofol MCT 2-8 mcg/ml using target-controlled infusion

All Listed Sponsors
lead

Chung-Ang University Gwangmyeong Hospital

OTHER

NCT06382467 - Comparison of Remimazolam and Propofol Combination vs. Propofol in IOM | Biotech Hunter | Biotech Hunter